- Oral presentation
- Open Access
The impact of a small parental network: how 11q improved research, knowledge, contacts and support
© van Betuw; licensee BioMed Central Ltd. 2010
- Published: 19 October 2010
- Public Health
- Time Frame
- Social Medium
- Personal Life
- European Level
After the birth of our daughter, Geertje Jongman, and being told about her very rare chromosomal disorder, my husband and I experienced what so many parents did: not knowing anything, feeling alone, with our world turned upside down. Many years later we decided to start a European network and thanks to immediate support of other parents, some researchers/scientists and the internet; we managed to build it up. I resigned some years ago, but it is still alive and kicking!
The European Chromosome 11q Network was formally founded in 1997. Looking back and comparing it to other small networks, I see that the way we did it, was good:
Set a goal
Make a plan and put it in a time frame
Use modern ways of communication
Consider the implications on your personal life and then decide if you still want to do it.
From the start parents decided that they should set goals and stay in control. A strong and positive network is able to find people who know about organisation, finance, modern ways of communication and most important: they try to understand each other and accept differences in culture and habits. Outcomes from our network: 6 conferences, several research projects and results and support for ‘new’ families. Most important: never being alone anymore.
Moreover 11q or as it is known now, the ‘European Chromosome 11 network’, is sometimes mentioned as an example how things can be done successfully at the European level. However, the network now stands for a new issue: is it necessary to set new goals, especially for the ultra rare chromosomal disorders? How to deal with new ways of communication like social media, e-health and online consulting? Is it possible to stay alive as a small network? It is interesting, and a challenge once again.
This article is published under license to BioMed Central Ltd.